Status: current, Defined. Date: 29-Feb 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1536481000168115 | Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4136271000168119 | Chelsea-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 3 x 28 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4143931000168119 | Chelsea-35 ED (cyproterone acetate 2 mg + ethinyloestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 3 x 28 tablets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | Is a | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 | true | Inferred relationship | Some | ||
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has TPUU | Chelsea-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | true | Inferred relationship | Some | 2 | |
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has TPUU | Chelsea-35 ED (inert substance) tablet | true | Inferred relationship | Some | 3 | |
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | true | Inferred relationship | Some | 1 | |
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has TP | Chelsea-35 ED | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs | Is a | True | Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR